Breakthroughs in MASH, with 89bio CEO
This week we’re focusing on an area of clinical research that has been of great interest for a number of years, that is NASH, also known as MASH. It’s a high area of unmet medical need, with over 20 million diagnosed cases across Europe and the USA, and while there are more than 80 therapies curren…
S5 - E26.2 - Looking Back at #TLM2024 - Patient Genotyping and MASH Clusters
Send us Fan Mail
In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation considers how the anticipated approval of a second MASH drug without biopsy might affect clinical trials and …
Diabetes Dialogue: Semaglutide for MASH in ESSENCE Trial, With Arun Sanyal, MD
Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at …
Understanding liver health and MASLD (Part 1)
A reversible liver condition is the fastest growing cause of liver transplantation in Western countries: Metabolic dysfunction-associated steatotic liver disease—or MASLD—affects patients worldwide. It’s characterized by excessive fat accumulation in the liver and can progress into more severe form…
Advancing liver care with non-invasive tests (Part 2)
Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as fatty liver disease, is a chronic liver condition that affects nearly 1 in 3 people worldwide. It is closely linked to obesity, type 2 diabetes, and metabolic syndrome. Unchecked, it can progress to a more severe form o…
Patients Come First Podcast - Dr. Arun Sanyal
This episode of VHHA’s Patients Come First podcast features Dr. Arun Sanyal, Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at VCU Health. Dr. Sanyal is a return guest who joins us to share insight about an exciting new clinical study showing that a medicine approv…
S4E2 - MASH: How to Treat and When to Refer
In this episode, our faculty, Arun Sanyal, MD and Mary Rinella, MD, discuss managing MASH in primary care. Learn how to stratify risk using noninvasive testing, initiate lifestyle and pharmacologic interventions, and recognize when to refer. Equip yourself with tools to improve outcomes before cirr…
S4E1 - MASH: Recognizing a “Silent” Disease
In this episode, our faculty, Arun Sanyal, MD and Mary Rinella, MD, discuss screening and early intervention of MASH, a silent but progressive liver disease. Dr. Sanyal and Dr. Rinella highlight the critical role of primary care physicians in early detection, risk assessment using noninvasive tests…
MASH: Recognizing a "Silent" Disease
Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic.
These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered …
MASH: How to Treat and When to Refer
Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic.
These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered …
PODCAST SÖKMOTOR
Du kan använda vår webbplats för att söka efter3,820,986podcaster och195,280,751avsnitt efter personer, platser eller ämnen.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
REDIGERA
Tack för att du hjälper till att hålla databasen över podcaster uppdaterad.
